OpenBilldrug price receipt

NADAC week of 2026-10-14

CLARINEX-D 12 HR 2.5-120 MG TB

FDA nonproprietary name: desloratadine and pseudoephedrine sulfate

For 30 tablets

Pharmacies pay

$182.05 filed

30 × $6.06832 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$162.87 filed

30 × $5.42902 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

0.89× estimated

Medicare paid 11% less than pharmacies pay.

Part D averages every strength and form sold under “Clarinex-D 12 Hour” / “Desloratadine/Pseudoephedrine” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$214.36 estimated

$182.05 + $27.31 (15%) + $5.00 fee per fill = $214.36

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

CLARINEX-D 12 HR 2.5-120 MG TB is how the CMS NADAC file names this product. The FDA NDC Directory lists it as desloratadine and pseudoephedrine sulfate, under the trade name “CLARINEX-D 12 HOUR”.

FDA gives its dosage form as tablet, extended release and its route as oral.

The labeler, the company named on the label, is Organon LLC.

FDA lists it under 2 Established Pharmacologic Classes: alpha-Adrenergic Agonist and Histamine-1 Receptor Antagonist.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 78206-0120-01.

NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $182.05 for 30 tablets (30 × $6.06832 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The NDC

Compared with its class

Its NADAC price is $6.06832 per EA filed.

Of the 59 other products in FDA’s alpha-Adrenergic Agonist class priced per EA, 7 have a higher middle NADAC price and 52 a lower one. The one in the middle is FEXOFENADINE-PSE ER 60-120 TAB, at $0.48321 per EA filed (eff. 2026-09-23).

Of the 109 other products in FDA’s Histamine-1 Receptor Antagonist class priced per EA, 2 have a higher middle NADAC price and 107 a lower one. The one in the middle is FT ALLERGY (CETRZN) 10 MG TAB, at $0.06128 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $162.87 for 30 tablets, at an average of $5.42902 per EA in 2024 (2024-01-01 to 2024-12-31) for “Clarinex-D 12 Hour” and “Desloratadine/Pseudoephedrine”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 1,225 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for CLARINEX-D 12 HR 2.5-120 MG TB labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Clarinex-D 12 Hour / Desloratadine/Pseudoephedrine: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on brand name.